Fred Alger Management, LLC Reata Pharmaceuticals Inc Transaction History

Fred Alger Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $18.4 Million - $24.5 Million	232,469 Added 133.07%	407,170 $41.5 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $41.2 Million - $124 Million	-1,334,703 Reduced 88.43%	174,701 $15.9 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $19.9 Million - $37.8 Million	897,481 Added 146.67%	1,509,404 $57.3 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $11.9 Million - $22.3 Million	611,923 New	611,923 $15.4 Million
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $756,639 - $1.07 Million	-8,028 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $18,467 - $33,416	-181 Reduced 2.2%	8,028 $992,000
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $783,313 - $1.37 Million	-8,375 Reduced 50.5%	8,209 $800,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $358,944 - $501,783	2,842 Added 20.68%	16,584 $2.59 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $650,846 - $1.3 Million	5,242 Added 61.67%	13,742 $1.98 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $410,134 - $1.2 Million	5,500 Added 183.33%	8,500 $1.74 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $213,780 - $287,250	3,000 New	3,000 $241,000
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $155,700 - $305,370	-3,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $146,280 - $229,320	3,000 New	3,000 $168,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.